Crimean-Congo hemorrhagic fever death toll in Turkey rises

Viral Hemorrhagic Fever

Aug 9, 2006 (CIDRAP News) – The number of deaths in a Crimean-Congo hemorrhagic fever (CCHF) outbreak in Turkey has increased to 20, with a total of 242 cases, the World Health Organization (WHO) reported yesterday.

Since WHO's last update on the outbreak on Jun 30 there have been 92 new cases and 9 new deaths. One of the fatalities involved a healthcare worker who acquired the infection while treating a patient with CCHF.

Lab-confirmed cases were reported in 22 Turkish provinces, though most were reported from six northeastern provinces of Kelkit Valley: Tokat, Sivas, Gumushane, Amasya, Yozgat, and Corum.

A Jul 10 WHO update on CCHF said most of the patients who were evaluated for the disease had been infected through tick bites. Contact with the blood of infected livestock can also transmit the virus.

CCHF is a viral hemorrhagic fever caused by Nairovirus organisms of the Bunyaviridae family. The disease is primarily a zoonosis; sporadic cases and outbreaks do occur in humans. The disease in humans is severe and has a high mortality rate. (The case-fatality rate in the current outbreak is 8.3%, according to the WHO.) CCHF is endemic in many African, European, and Asian countries.

In an advisory for travelers, the European Centre for Disease Prevention and Control (ECDC) said no cases have been reported from popular tourist resorts on Turkey's Mediterranean coast. The ECDC said the number of cases in 2006 suggests increased viral activity in the area; however, they added that detection and diagnosis of CCHF have improved. In Turkey, CCHF in humans was first documented in 2002.

A note posted today on ProMED-mail, the online reporting system of the International Society for Infectious Diseases, said the death of the healthcare worker serves as an important reminder that those treating suspected CCHF patients should take proper infection control precautions during their exposure to infected patients. Nosocomial infection risk is highest in the early stages of a patient's infection.

The Turkish Ministry of Health is continuing control measures, which include enhanced nationwide CCHF surveillance. The WHO Country Office in Turkey and the WHO Regional Office for Europe are closely monitoring CCHF activity in the country.

See also:

Aug 8 WHO update on CCHF outbreak in Turkey
http://www.who.int/csr/don/2006_08_08b/en/index.html

WHO fact sheet on Crimean-Congo hemorrhagic fever
http://www.who.int/mediacentre/factsheets/fs208/en/

Aug 9 ProMED-Mail posting on CCHF in Turkey

CIDRAP overview on viral hemorrhagic fever
http://www.cidrap.umn.edu/cidrap/content/bt/vhf/biofacts/index.html

This week's top reads

  1. Woman dies from brain ameba after flushing nose with RV water

    The woman had amebic meningoencephalitis, a rare, often fatal brain infection caused by the ameba Naegleria fowleri.

    Jim Wappes
    Neti pot in use

  2. 'A national scandal': US excess deaths rose even after pandemic, far outpacing peer countries

    The United States has been in a "protracted health crisis" for decades, the researchers say.

    Mary Van Beusekom
    Grave markers with flowers

  3. US measles total nears 1,100 cases as Colorado reports airline cluster

    Some of the latest cases are tied to a large outbreak centered in West Texas, while others are linked to instances of community transmission or travel to other states or countries.

    Lisa Schnirring
    airline passengers

  4. WHO warns of rising COVID activity in 3 global regions

    The increase in activity is seen in the Western Pacific, Southeast Asia, and Eastern Mediterranean regions.

    Stephanie Soucheray

  5. FDA vaccine advisers recommend sticking with JN.1 strain for next COVID vaccines

    The group weighed considerations about newer variants and raised concerns that a strain recommendation might interface with the FDA's new proposed COVID vaccine framework.

    Lisa Schnirring
    woman vaccinated

  6. Long-COVID symptoms in young kids can vary by age

    Preschool-aged children were more likely to have a dry cough and daytime tiredness or low energy.

    Stephanie Soucheray
    sick boy cough

  7. WHO adds NB.1.8.1 as SARS-CoV-2 variant under monitoring

    Experts say illnesses don't seem more severe and more studies are needed to further assess the risk of antibody escape.

    Lisa Schnirring

  8. Prior COVID vaccination produces immune response against new SARS-CoV-2 strains, study finds

    Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their variant infections than in those who had been vaccine-naive.

    Stephanie Soucheray

  9. HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines

    Buoyed by promising clinical findings, Moderna says it will explore alternatives for late-stage development of the H5 vaccine.

    Lisa Schnirring
    syringe and vial

  10. Iowa, Nebraska announce first measles cases

    Iowa's patient is an unvaccinated adult, and Nebraska's is a vaccinated child who had not traveled outside the state.

    Lisa Schnirring
    measles torso

Our underwriters